648
Views
12
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

A dental look at the autistic patient through orofacial pain

, , &
Pages 193-200 | Received 02 Sep 2010, Accepted 25 Nov 2010, Published online: 13 Jan 2011

References

  • Gadia CA, Tuchman R, Rotta NT. Autism and pervasive developmental disorders. J Pediatr (Rio J) 2004;80:S83–94 (in Portugeuse).
  • Casanova MF. The neuropathology of autism. Brain Pathol 2007;17:422–33.
  • Rapin I, Tuchman RF. Autism: definition, neurobiology, screening, diagnosis. Pediatr Clin North Am 2008;55:1129–46, viii.
  • Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol 2001;429:23–37.
  • Scully C, Shotts R. ABC of oral health. Mouth ulcers and other causes of orofacial soreness and pain. BMJ 2000;321:162–5.
  • Siqueira JT, Lin HC, Nasri C, Siqueira SR, Teixeira MJ, Heir G, Clinical study of patients with persistent orofacial pain. Arq Neuropsiquiatr 2004;62:988–96.
  • Sarlani E, Balciunas BA, Grace EG. Orofacial pain–Part I: Assessment and management of musculoskeletal and neuropathic causes. AACN Clin Issues 2005;16:333–46.
  • Sarlani E, Balciunas BA, Grace EG. Orofacial Pain–Part II: Assessment and management of vascular, neurovascular, idiopathic, secondary, and psychogenic causes. AACN Clin Issues 2005;16:347–58.
  • Spencer CJ, Gremillion HA. Neuropathic orofacial pain: proposed mechanisms, diagnosis, and treatment considerations. Dent Clin North Am 2007;51:209–24.
  • Graff-Radford SB. Facial pain. Curr Opin Neurol 2000;13:291–6.
  • Haraldstad K, Sorum R, Eide H, Natvig GK, Helseth S. Pain in children and adolescents: prevalence, impact on daily life, and parents' perception, a school survey. Scand J Caring Sci 2010 Apr 13 [Epub ahead of print].
  • Sessle BJ. Why are the diagnosis and management of orofacial pain so challenging? J Can Dent Assoc 2009;75:275–7.
  • Friedlander AH, Yagiela JA, Paterno VI, Mahler ME. The pathophysiology, medical management, and dental implications of autism. J Calif Dent Assoc 2003;31:681–2, 684, 684–91.
  • Friedlander AH, Yagiela JA, Paterno VI, Mahler ME. The neuropathology, medical management and dental implications of autism. J Am Dent Assoc 2006;137:1517–27.
  • Clark GT, Ram S. Four oral motor disorders: bruxism, dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions. Dent Clin North Am 2007;51:225–43, viii–ix.
  • Muthu MS, Prathibha KM. Management of a child with autism and severe bruxism: a case report. J Indian Soc Pedod Prev Dent 2008;26:82–4.
  • Lavigne GJ, Khoury S, Abe S, Yamaguchi T, Raphael K. Bruxism physiology and pathology: an overview for clinicians. J Oral Rehabil 2008;35:476–94.
  • Svensson P, Jadidi F, Arima T, Baad-Hansen L, Sessle BJ. Relationships between craniofacial pain and bruxism. J Oral Rehabil 2008;35:524–47.
  • Tolosa E, Marti MJ. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects. Adv Neurol 1988;49:73–84.
  • Klawans HL, Tanner CM, Goetz CG. Epidemiology and pathophysiology of tardive dyskinesias. Adv Neurol 1988;49:185–97.
  • Blanchet PJ, Rompre PH, Lavigne GJ, Lamarche C. Oral dyskinesia: a clinical overview. Int J Prosthodont 2005;18:10–9.
  • Casey DE. Pathophysiology of antipsychotic drug-induced movement disorders. J Clin Psychiatry 2004;65(Suppl 9):25–8.
  • Blanchet PJ, Popovici R, Guitard F, Rompre PH, Lamarche C, Lavigne GJ. Pain and denture condition in edentulous orodyskinesia: comparisons with tardive dyskinesia and control subjects. Mov Disord 2008;23:1837–42.
  • Lee KH. Oromandibular dystonia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104:491–6.
  • Carlson CD, Cavazzoni PA, Berg PH, Wei H, Beasley CM, Kane JM. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine. J Clin Psychiatry 2003;64:898–906.
  • Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009;373:31–41.
  • Scott LJ, Dhillon S. Risperidone: a review of its use in the treatment of irritability associated with autistic disorder in children and adolescents. Paediatr Drugs 2007;9:343–54.
  • Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004;140:441–51.
  • Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl 1986;3:S1–226.
  • Ren K, Dubner R. Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr Opin Anaesthesiol 2008;21:570–9.
  • Okada-Ogawa A, Suzuki I, Sessle BJ, Chiang CY, Salter MW, Dostrovsky JO, Astroglia in medullary dorsal horn (trigeminal spinal subnucleus caudalis) are involved in trigeminal neuropathic pain mechanisms. J Neurosci 2009;29:11161–71.
  • Guo W, Wang H, Watanabe M, Shimizu K, Zou S, LaGraize SC, Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 2007;27:6006–18.
  • Avivi-Arber L, Lee JC, Sessle BJ. Effects of incisor extraction on jaw and tongue motor representations within face sensorimotor cortex of adult rats. J Comp Neurol 2010;518:1030–45.
  • Suter MR, Wen YR, Decosterd I, Ji RR. Do glial cells control pain? Neuron Glia Biol 2007;3:255–68.
  • Nelson KB, Grether JK, Croen LA, Dambrosia JM, Dickens BF, Jelliffe LL, Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 2001;49:597–606.
  • Miyazaki K, Narita N, Sakuta R, Miyahara T, Naruse H, Okado N, Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain Dev 2004;26:292–5.
  • Pardo CA, Eberhart CG. The neurobiology of autism. Brain Pathol 2007;17:434–47.
  • Zakrzewska JM. Facial pain: neurological and non-neurological. J Neurol Neurosurg Psychiatry 2002;72(Suppl 2):ii27–ii32.
  • Scully C, Porter S. Orofacial disease: update for the clinical team: 9. Orofacial pain. Dent Update 1999;26:410–17.
  • Benoeliel R, Pertes RA, Eliav E. Orofacial pain: Current therapy in pain. In: Smith H, editor. Saunders Elsevier: Philadelphia, PA; 2009. p. 121.
  • Ricketts DN, Pitts NB. Traditional operative treatment options. Monogr Oral Sci 2009;21:164–73.
  • Palkovicova L, Ursinyova M, Masanova V, Yu Z, Hertz-Picciotto I. Maternal amalgam dental fillings as the source of mercury exposure in developing fetus and newborn. J Expo Sci Environ Epidemiol 2008;18:326–31.
  • Guzzi G, Grandi M, Cattaneo C. Should amalgam fillings be removed? Lancet 2002;360:2081.
  • Pizzichini M, Fonzi M, Giannerini F, Mencarelli M, Gasparoni A, Rocchi G, Influence of amalgam fillings on Hg levels and total antioxidant activity in plasma of healthy donors. Sci Total Environ 2003;301:43–50.
  • Weiner JA, Nylander M. The relationship between mercury concentration in human organs and different predictor variables. Sci Total Environ 1993;138:101–15.
  • Mutter J, Naumann J, Guethlin C. Comments on the article “the toxicology of mercury and its chemical compounds” by Clarkson and Magos (2006). Crit Rev Toxicol 2007;37:537–49.
  • Ask K, Akesson A, Berglund M, Vahter M. Inorganic mercury and methylmercury in placentas of Swedish women. Environ Health Perspect 2002;110:523–6.
  • Drasch G, Schupp I, Hofl H, Reinke R, Roider G. Mercury burden of human fetal and infant tissues. Eur J Pediatr 1994;153:607–10.
  • Luglie PF, Campus G, Chessa G, Spano G, Capobianco G, Fadda GM, Effect of amalgam fillings on the mercury concentration in human amniotic fluid. Arch Gynecol Obstet 2005;271:138–42.
  • Vimy MJ, Hooper DE, King WW, Lorscheider FL. Mercury from maternal “silver” tooth fillings in sheep and human breast milk. A source of neonatal exposure. Biol Trace Elem Res 1997;56:143–52.
  • Nelson BK. Evidence for behavioral teratogenicity in humans. J Appl Toxicol 1991;11:33–7.
  • National Research Council Committee on the toxicology of methymercury. Toxicological effects of methylmercury. Washington D.C.: Nacional Academy Press; 2000.
  • Mutter J, Naumann J, Schneider R, Walach H, Haley B. Mercury and autism: accelerating evidence? Neuro Endocrinol Lett 2005;26:439–46.
  • Bernard S, Enayati A, Roger H, Binstock T, Redwood L. The role of mercury in the pathogenesis of autism. Mol Psychiatry 2002;7(Suppl 2):S42–3.
  • Geier DA, King PG, Sykes LK, Geier MR. A comprehensive review of mercury provoked autism. Indian J Med Res 2008;128:383–411.
  • Geier DA, Kern JK, Geier MR. A prospective study of prenatal mercury exposure from maternal dental amalgams and autism severity. Acta Neurobiol Exp (Wars) 2009;69:189–97.
  • Palmer RF, Blanchard S, Wood R. Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place 2009;15:18–24.
  • Clarkson TW, Magos L. The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 2006;36:609–62.
  • Echeverria D, Woods JS, Heyer NJ, Rohlman D, Farin FM, Li T, The association between a genetic polymorphism of coproporphyrinogen oxidase, dental mercury exposure and neurobehavioral response in humans. Neurotoxicol Teratol 2006;28:39–48.
  • Sugita M. The biological half-time of heavy metals. The existence of a third, “slowest” component. Int Arch Occup Environ Health 1978;41:25–40.
  • Loo CY, Graham RM, Hughes CV. The caries experience and behavior of dental patients with autism spectrum disorder. J Am Dent Assoc 2008;139:1518–24.
  • Rada RE. Controversial issues in treating the dental patient with autism. J Am Dent Assoc 2010;141:947–53.
  • Rogers SJ, Ozonoff S. Annotation: what do we know about sensory dysfunction in autism? A critical review of the empirical evidence. J Child Psychol Psychiatry 2005;46:1255–68.
  • Tuchman R. Treatment of seizure disorders and EEG abnormalities in children with autism spectrum disorders. J Autism Dev Disord 2000;30:485–9.
  • Malone RP, Waheed A. The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism. Drugs 2009;69:535–48.
  • Friedlander AH, Yagiela JA, Mahler ME, Rubin R. The pathophysiology, medical management and dental implications of adult attention-deficit/hyperactivity disorder. J Am Dent Assoc 2007;138:475–82.
  • Robbins MR. Dental management of special needs patients who have epilepsy. Dent Clin North Am 2009;53:295–309, ix.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.